1569263-06-4

1569263-06-4 structure

1569263-06-4 structure

Name: Rinucumab
Chemical Name: Rinucumab
CAS Number: 1569263-06-4
Molecular Formula:
Molecular Weight:
Catalog: Signaling Pathways Protein Tyrosine Kinase/RTK PDGFR
Create Date: 2023-01-17 16:02:43
Modify Date: 2024-04-09 17:45:44
Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration[1].

Name	Rinucumab

Description	Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration[1].
Related Catalog	Signaling Pathways >> Protein Tyrosine Kinase/RTK >> PDGFR Research Areas >> Metabolic Disease
References	[1]. Megan Cully, et al. Deal watch: Novartis eyes vision-enhancing therapy for macular degeneration. Nat Rev Drug Discov. 2014 Jul;13(7):487.

No Any Chemical & Physical Properties